WeChat Mini Program
Old Version Features

Neoadjuvant Sintilimab Plus Chemotherapy in EGFRmutant NSCLC Followed by Adjuvant Osimertinib or Observation: A Phase II CTONG2104 Trial

C. Zhang,B-y Jiang,L-x Yan, Z-y Chen, C. Lv, Y-s Li,S. Dong,R-q Liao,X-n Yang, Q. Zhou,Y-L Wu,W-z Zhong

JOURNAL OF THORACIC ONCOLOGY（2024）

Cited 0|Views1
Key words
NSCLC,EGFR,Neoadjuvant
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined